Metraipolis › archive › dc_f1408ccdee91

FDG PET/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report — Europe PMC PMID:42077576

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42077576
DOI
10.1055/s-[numero omesso]
License (as archived)
solo-consultazione
Archived
2026-11-03T22:18:50.255Z
SHA-256 of the archived text
768dc4c83caff062ea4e2fe95725249dd1d17d8fe3d7fe19804acc3c741690c4
Stable URL of this page
https://metraipolis.com/documento/dc_f1408ccdee91

How to cite

FDG PET/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report — Europe PMC PMID:42077576 — Europe PMC (en), https://europepmc.org/article/MED/42077576 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f1408ccdee91 (Metraipolis archive dc_f1408ccdee91, sha256 768dc4c83caff062ea4e2fe95725249dd1d17d8fe3d7fe19804acc3c741690c4)
BibTeX
@misc{dcf1408ccdee91,
  title = {FDG PET/CT as the Decisive Modality in Distinguishing Clear Cell Sarcoma from Melanoma When Immunohistochemistry Overlaps: A Case Report — Europe PMC PMID:42077576},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42077576},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f1408ccdee91; sha256 768dc4c83caff062ea4e2fe95725249dd1d17d8fe3d7fe19804acc3c741690c4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42077576. Agents can read the archived copy with the MCP tool read_document.